Florence announced it had raised $80 million in its Series C round in May 2021.
The web service estimates a user's psychological age and creates a personalised mental health programme.
Of the 224 companies analyzed, 98 received a clinical robustness score of zero.
CMS did not explicitly concur with the OIG's recommendation to develop its own source of race and ethnicity data.
This follows last year's FDA approvals in the US.
Equip CEO and cofounder Kristina Saffran discusses the virtual eating disorder treatment startup's nationwide expansion and why the space needs more research and innovation.
Also: Oma Fertility emerges from stealth with $37.5 million in equity and debt financing, and payer data platform Abacus Insights scores $28 million.
The startup's smartphone-administered digital therapeutic for fibromyalgia received FDA Breakthrough Device designation last year.
The company is leveraging its own portfolio and partner digital assets to directly engage patients at home, virtually or in-person.

FOLLOW ME

0FansLike
0FollowersFollow
0SubscribersSubscribe

POPULAR ARTICLES